BRAIDWELL LP
CIK 1920938 · Holdings on Jun 30, 2024 · First reported Aug 14, 2024
Top ten holdings
Q2 2024- GH6.53%
- 10806XAB84.48%
- NVCR4.07%
- 670704AJ43.45%
- NBIX3.28%
- CGON3.28%
- XENE3.13%
- APGE2.95%
- 64049MAB62.85%
- 46333XAH12.66%
Share classes counted separately36.68%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- CGONWeight increased · +1.68 pp1.60% → 3.28%Shares +2.18M (+192.82%)
- XENEWeight increased · +1.32 pp1.81% → 3.13%Shares +1.25M (+95.76%)
- SYREWeight increased · +1.22 pp0.63% → 1.85%Shares +2.00M (+388.26%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | GHGUARDANT HEALTH INCNOTE11/1 View history and evidence | $208.12M | 6.53% | 268.25M principal (USD) | 5.92% → 6.53%+0.61 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | 10806XAB8BRIDGEBIO PHARMA INCNOTE 2.500% 3/1 View history and evidence | $142.97M | 4.48% | 140.84M principal (USD) | 4.71% → 4.48%-0.23 pp +5.00M (+3.68%) | Added | ↗▾ |
| 03 | NVCRNOVOCURE LTDNOTE11/0 View history and evidence | $129.79M | 4.07% | 140.83M principal (USD) | 4.02% → 4.07%+0.05 pp +5.00M (+3.68%) | Added | ↗▾ |
| 04 | 670704AJ4NUVASIVE INCNOTE 0.375% 3/1 View history and evidence | $110.07M | 3.45% | 114.21M principal (USD) | 3.51% → 3.45%-0.06 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | NBIXNEUROCRINE BIOSCIENCES INC View history and evidence | $104.49M | 3.28% | 759.01K shares | 3.25% → 3.28%+0.03 pp +28.80K (+3.94%) | Added | ↗▾ |
| 06 | CGONCG ONCOLOGY INC View history and evidence | $104.48M | 3.28% | 3.31M shares | 1.60% → 3.28%+1.68 pp +2.18M (+192.82%) | Added | ↗▾ |
| 07 | XENEXENON PHARMACEUTICALS INC View history and evidence | $99.84M | 3.13% | 2.56M shares | 1.81% → 3.13%+1.32 pp +1.25M (+95.76%) | Added | ↗▾ |
| 08 | APGEAPOGEE THERAPEUTICS INC View history and evidence | $94.13M | 2.95% | 2.39M shares | 3.95% → 2.95%-1.00 pp +549.53K (+29.82%) | Added | ↗▾ |
| 09 | 64049MAB6NEOGENOMICS INCNOTE 0.250% 1/1 View history and evidence | $90.85M | 2.85% | 116.38M principal (USD) | 2.66% → 2.85%+0.19 pp +12.80M (+12.36%) | Added | ↗▾ |
| 10 | 46333XAH1IRONWOOD PHARMACEUTICALSNOTE 1.500% 6/1 View history and evidence | $84.65M | 2.66% | 89.74M principal (USD) | 1.73% → 2.66%+0.93 pp +37.00M (+70.16%) | Added | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 16
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| 457669AA7 INSMED INC | Non-derivative | -64,887,000 | -$69.43M | SEC filing ↗ | SEC filing ↗ |
| 05337M104 AVADEL PHARMACEUTICALS PLC | Non-derivative | -2,668,549 | -$45.07M | SEC filing ↗ | SEC filing ↗ |
| 48576UAA4 KARYOPHARM THERAPEUTICS | Non-derivative | -65,976,000 | -$35.79M | SEC filing ↗ | SEC filing ↗ |
3 / 16 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1920938 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 3187767909
}Research all 75 reported holdings.
This page includes 30 of 75 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 75 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1920938","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1920938","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.